| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.25 | 5e-07 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-07 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.27 | 2e-06 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.2 | 2e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.23 | 2e-05 |